Unilabs streamlines laboratory operations with analyzers from CellaVision
(Thomson Reuters ONE) -
CellaVision, which develops and sells products for routine analysis of blood and
other body fluids in health care, has signed a contract with the diagnostics
company Unilabs for installation of CellaVision's solution for automation of
manual blood analysis at laboratories in Stockholm and Skövde, Sweden. The order
consists of two analyzers and CellaVision's remote review software for assessing
patients' cell images. The solution has been in place since earlier this year at
Unilab's medical services laboratory in Eskilstuna.
"The order confirms our ability to solve competency problems that exist in both
private and public sector laboratory operations and we are very proud of gaining
the trust of such a strong quality and service-minded customer as Unilabs. We
hope that more units within Unilabs in Europe will see the advantages of the
solution and want to analyze samples digitally using our systems", says Yvonne
Mårtensson, CellaVision's CEO.
The Unilabs laboratory chain has decided to digitalize its clinical chemistry
analyses using CellaVision's analyzer CellaVision® DM1200 and the CellaVision®
Remote Review Software for assessing samples remotely. The analyzer has been
used since spring 2010 by Unilabs in Eskilstuna, where the solution has
performed well in streamlining the workflow at the laboratory and preventing the
competence shortage that the large-scale retirement of bioanalysts in coming
years is expected to create.
"With CellaVision's products we will be more competitive in tenders for services
in laboratory medicine", says Lennart Nordström, Medical Director, Clinical
Chemistry at Unilabs. "The solution makes it possible to consult colleagues at
other laboratories faster and discuss cell images and results of analyses. In
that way we can give even better service to our customers."
The CellaVision DM1200 is CellaVision's newest analyzer and is intended for
clinical laboratories with mid-sized sample volumes of blood and other body
fluids. The analyzer replaces a manual microscope and offers health care
services a faster and more standardized way of counting and grouping cells,
which is a common analysis when diagnosing a number of illnesses, such as
infections, inflammations, anemia and serious cancers. The analyzer has been
available for about a year in CellaVision's main markets, Europe and North
America, where the product meets with great interest among hospital laboratories
and commercial laboratories due to its sound qualities for timesaving,
standardization and exchange of information within and between units.
For further information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Telephone: 0708 33 77 82. Email:yvonne.martensson(at)cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The analyses constitute critical reference data
for fast and correct diagnosis of illnesses, for example of infections and
serious cancers. CellaVision's products rationalize manual laboratory work, and
secure and support effective workflows and skills development within and between
hospitals. The company has leading-edge expertise in image analysis, artificial
intelligence and automated microscopy. In 2009 sales were SEK 109 million and
sales continue to increase, with a growth target of at least 15 % per year over
an economic cycle. CellaVision's registered office is in Lund and the company
has subsidiaries in the USA, Canada and Japan. The share is listed on the
Nasdaq, OMX Stockholm, Small Cap list. Read more atwww.cellavision.com
About Unilabs
Unilabs is one of Europe's leading diagnostics companies, operating in
laboratory medicine and radiology services at 90 laboratories in twelve
countries. The company offers services in laboratory medicine and image and
function diagnostics to outpatient and inpatient health care. High quality,
security and service are the hallmarks of the company's services. The operations
in Sweden are conducted at 11 hospitals, 2 local walk-in clinics, 20 primary
care laboratories and three independent surgeries. The company's sales are about
SEK 800 million on an annual basis and it has more than 700 employees, mainly
biomedical analysts, radiology nurses and doctors with specialist skills in
radiology or laboratory medicine. Clients are outpatient and inpatient care
providers in the public and private sectors. Read more atwww.unilabs.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1474508]
Unternehmensinformation / Kurzprofil:
Datum: 21.12.2010 - 09:37 Uhr
Sprache: Deutsch
News-ID 49937
Anzahl Zeichen: 5565
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 369 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Unilabs streamlines laboratory operations with analyzers from CellaVision"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
